Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DENN
751
DELISTED
Denny's
DENN
| $602K | 0.01% |
30,293
+14,754
| +95% | +$304K |
|
752
Canadian National Railway
CNI
$78.5B
| $601K | 0.01% |
6,650
-11,485
| -63% | -$1.03M |
|
|
NXGN
753
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $601K | 0.01% |
37,394
-20,229
| -35% | -$334K |
|
754
American States Water
AWR
$3.51B
| $592K | 0.01% |
6,828
+272
| +4% | +$24.1K |
|
755
Datadog
DDOG
$84.6B
| $591K | 0.01% |
+15,633
| New | +$562K |
|
756
Dillards
DDS
$9.71B
| $590K | 0.01% |
8,031
-4,055
| -34% | -$287K |
|
757
Loews
L
$22.5B
| $590K | 0.01% |
11,232
-6,406
| -36% | -$323K |
|
758
Ormat Technologies
ORA
$6.67B
| $590K | 0.01% |
7,920
-13,660
| -63% | -$1.03M |
|
759
Planet Fitness
PLNT
$4.09B
| $590K | 0.01% |
7,907
-54,402
| -87% | -$3.67M |
|
760
Deckers Outdoor
DECK
$12.5B
| $585K | 0.01% |
20,784
-44,562
| -68% | -$1.18M |
|
761
Ziff Davis
ZD
$1.92B
| $585K | 0.01% |
7,176
-13,142
| -65% | -$1.09M |
|
|
AMTD
762
DELISTED
TD Ameritrade Holding Corp
AMTD
| $585K | 0.01% |
+11,779
| New | +$510K |
|
|
CISN
763
DELISTED
Cision Ltd. Ordinary Share
CISN
| $584K | 0.01% |
58,620
-83,131
| -59% | -$794K |
|
764
Equifax
EFX
$22.6B
| $583K | 0.01% |
+4,163
| New | +$577K |
|
765
Rogers Communications
RCI
$19.6B
| $580K | 0.01% |
11,679
-13,956
| -54% | -$673K |
|
766
Generac Holdings
GNRC
$12.2B
| $578K | 0.01% |
5,743
-168
| -3% | -$15.6K |
|
767
Emergent Biosolutions
EBS
$260M
| $577K | 0.01% |
10,704
| – | – |
|
768
Chegg
CHGG
$90.8M
| $575K | 0.01% |
+15,158
| New | +$530K |
|
769
W.W. Grainger
GWW
$61.8B
| $575K | 0.01% |
1,698
-2,342
| -58% | -$743K |
|
770
Lamar Advertising Co
LAMR
$15.3B
| $574K | 0.01% |
6,426
-91
| -1% | -$7.61K |
|
771
Marriott Vacations Worldwide
VAC
$3.87B
| $570K | 0.01% |
4,426
+1,141
| +35% | +$134K |
|
|
CERN
772
DELISTED
Cerner Corp
CERN
| $570K | 0.01% |
7,770
-1,951
| -20% | -$135K |
|
|
ICPT
773
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $566K | 0.01% |
+4,567
| New | +$409K |
|
774
Lantheus
LNTH
$6.53B
| $565K | 0.01% |
27,539
+12,291
| +81% | +$249K |
|
|
PLAN
775
DELISTED
Anaplan, Inc.
PLAN
| $564K | 0.01% |
+10,756
| New | +$534K |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.